Progenics Pharmaceuticals Announces Pricing of Public Offering of Common Stock

[at noodls] – TARRYTOWN, N.Y., Feb. 21, 2014 (GLOBE NEWSWIRE) — Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) announced today the pricing of an underwritten public offering of 7,608,696 primary shares of its common … more

View todays social media effects on PGNX

View the latest stocks trending across Twitter. Click to view dashboard

See who Progenics is hiring next, click here to view